Mbudzi 14, 2025, inocherekedza zuva rechigumi nepfumbamwe reUN Diabetes Day, ine dingindira rekusimudzira "Chirwere cheshuga uye Hupenyu". Inosimbisa kuisa kuvandudzwa kwehupenyu hwevanhu vane chirwere cheshuga pakati pehutano hwehutano hwehutano, zvichiita kuti varwere vanakidzwe nehupenyu hwakanaka.
Pasi rose, vanhu vakuru vanosvika 589 miriyoni (vane makore 20-79) vane chirwere cheshuga, chinomiririra 11.1% (1 mu9) yezera iri. Vanosvika 252 miriyoni vanhu (43%) havasati vaonekwa, vakatarisana nenjodzi huru yekunetsekana. Huwandu hwevanhu vane chirwere cheshuga hunotarisirwa kukwira kusvika 853 miriyoni ne2050, kuwedzera kwe45%.
Etiology uye Clinical Types dzeDiabetes
Chirwere cheshuga nhevedzano ye metabolic disorder syndromes inosanganisira shuga, mapuroteni, mafuta, mvura, uye electrolytes, inokonzerwa neakasiyana pathogenic zvinhu senge genetic factor, immune system kusagadzikana, hutachiona hwehutachiona uye chepfu, mahara radical toxin, uye pfungwa dzinobata pamuviri. Zvinhu izvi zvinotungamirira kune islet function kukanganisa, insulin resistance, etc. Clinically, inoratidzirwa zvikuru ne hyperglycemia. Mhosva dzakajairika dzinogona kuuya ne polyuria, polydipsia, polyphagia, uye kurasikirwa nehuremu, inozivikanwa se "mapoly matatu uye imwe kurasikirwa" zviratidzo. Inoiswa mukiriniki muRudzi 1 chirwere cheshuga, Type 2 chirwere cheshuga, Gestational chirwere cheshuga, uye Mamwe marudzi chaiwo echirwere cheshuga.
Diabetes Detection Biomarkers
Islet autoantibodies chiratidzo chekuparadzwa kwe pancreatic β masero uye zviratidzo zvakakosha zvekuongorora chirwere cheshuga che autoimmune. Glutamic acid decarboxylase antibodies (GAD), tyrosine phosphatase antibodies (IA-2A), insulin antibodies (IAA), uye islet cell masoja ekudzivirira chirwere (ICA) akakosha immunological marker yekuonekwa kwekiriniki kwechirwere cheshuga.
Ongororo dzakawanda dzakaratidza kuti kusangana kwakasanganiswa kunogona kuvandudza mwero wekuonekwa kweautoimmune diabetes. Kuwanda kwenhamba yemasoja ekudzivirira chirwere anomuka kare, ndiko kuwedzera kwenjodzi yemunhu akurumidze kufambira mberi kusvika kuchipatara chirwere cheshuga.
Tsvagiridzo inoratidza:
● Vanhu vane masoja ekudzivirira chirwere matatu kana kupfuura ane mikana > 50% yekubatwa nechirwere cheshuga cheRudzi 1 mukati memakore mashanu.
● Vanhu vane masoja ekudzivirira zvirwere maviri vane mukana we70% wekubatwa nechirwere cheshuga cheRudzi 1 mukati memakore gumi, 84% mukati memakore gumi nemashanu, uye vanosvika 100% vanofambira mberi kusvika paType 1 chirwere cheshuga mushure memakore makumi maviri ekutevera.
● Vanhu vane masoja ekudzivirira chirwere anongova nechikamu che14,5% chete chekuva nechirwere cheshuga cheType 1 mukati memakore gumi.
Mushure mekuonekwa kwemasoja ekudzivirira chirwere, chiyero chekufambira mberi kune Type 1 chirwere cheshuga chine chekuita nemhando dzemasoja ekudzivirira chirwere, zera rekuonekwa kwemasoja ekudzivirira chirwere, murume kana mukadzi, uye HLA genotype.
Beier Inopa Yakakwana Kuongororwa Kweshuga
Beier's diabetes product series nzira dzinosanganisira Chemiluminescence Immunoassay (CLIA) uye Enzyme-Linked Immunosorbent Assay (ELISA). Kuonekwa kwakasanganiswa kwema biomarkers anobatsira mukuwanikwa kwekutanga, kutungamira kwehutano hwekutanga, uye kurapwa kwekutanga kwechirwere cheshuga, nekudaro kuvandudza hutano hwevanhu.
|
| Product Name |
| 1 | Anti-Islet Cell Antibody (ICA) Test Kit (CLIA) / (ELISA) |
| 2 | Anti-Insulin Antibody (IAA) Assay Kit (CLIA) / (ELISA) |
| 3 | Glutamic Acid Decarboxylase Antibody (GAD) Assay Kit (CLIA) / (ELISA) |
| 4 | Tyrosine Phosphatase Antibody (IA-2A) Assay Kit (CLIA) / (ELISA) |
References:
1. Chinese Diabetes Society, Chinese Medical Doctor Association Endocrinologist Branch, Chinese Society of Endocrinology, et al. Nhungamiro yekuongororwa uye kurapwa kwechirwere cheshuga 1 muChina (2021 edition) [J]. Chinese Journal yeDiabetes Mellitus, 2022, 14 (11): 1143-1250. DOI: 10.3760/cma.j.cn115791-20220916-00474.
2. Chinese Women Medical Doctors Association Diabetes Professional Committee, Editorial Board yeChinese Journal of Health Management, China Health Promotion Foundation. Nyanzvi kubvumirana pakuongorora uye kupindira kwechirwere cheshuga chepamusoro-soro vanhu muChina. Chinese Journal of Health Management, 2022, 16(01): 7-14. DOI: 10.3760/cma.j.cn115624-20211111-00677.
Nguva yekutumira: Nov-17-2025
